IDACORP, Inc. IDA
147.48 USD +2.36 (+1.63%)
At closeNov 5, 2026, 7:22 AM EST
145.20 -2.28 -1.55%
Pre-market · Nov 5, 7:22 AM ET
145.05 Day range 148.04
124.12 52-week range 154.91
- YTD
- +16.53%
- 1 year
- +13.82%
Analyst view
Consensus: buy
Buy
Price target (mean) 154.22 +4.6% upside
Now 147.48
- Target (low)
- 144.00
- Target (mean)
- 154.22
- Target (high)
- 170.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.84414 | 0.72 – 1.08 | 0.78 | +8.2% | 571.02M | +40.9% | 7 |
| Next quarter | 1.33 | 1.17 – 1.59 | 1.21 | +10.1% | 491.45M | +21.8% | 6 |
| Current year | 6.42 | 6.36 – 6.50 | 5.90 | +8.9% | 2.03B | +11.8% | 9 |
| Next year | 6.98 | 6.89 – 7.09 | 6.42 | +8.7% | 2.21B | +8.9% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 18, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 22, 2026 | Wells Fargo | Upgrade | Underweight | Equal-Weight |
| May 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 20, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 20, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 2, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 28, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 20, 2026 | Wells Fargo | Downgrade | Equal-Weight | Underweight |
| Jan 14, 2026 | Barclays | Initiated | — | Overweight |
| Dec 17, 2025 | UBS | Maintained | Neutral | Neutral |
| Dec 16, 2025 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Dec 1, 2025 | Jefferies | Maintained | Buy | Buy |
| Oct 28, 2025 | Wells Fargo | Initiated | — | Equal-Weight |
| Oct 27, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Oct 22, 2025 | Jefferies | Maintained | Buy | Buy |
| Sep 26, 2025 | Jefferies | Maintained | Buy | Buy |
| Sep 25, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 11, 2025 | UBS | Maintained | Neutral | Neutral |
| Jun 2, 2025 | UBS | Maintained | Neutral | Neutral |
| May 22, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 2, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |